Navigation Links
ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
Date:11/4/2010

he Company ended the first quarter of fiscal 2011 with $10.2 million in cash versus $10.7 million in cash at the end of fiscal 2010.

"For the fifth consecutive quarter, we have improved our bottom line performance.  We reduced our net loss by $2.1 million in the first quarter of fiscal 2011 compared to the first quarter of fiscal 2010. Absent the severance, restructuring and lease termination charges, we would have achieved a profitable quarter," said J. Melville Engle, Chairman and Chief Executive Officer.

"Our year-over-year revenue growth was driven by a 73 percent increase in AXP® AutoXpress™ (AXP) System bag set revenues.  However, it should be noted that AXP disposable sales were higher than the prior year same quarter by $1.2 million, due primarily to GE Healthcare (GEHC) increasing their inventory levels approximately $1.0 million to meet certain customer requirements.  We do not expect these inventory accumulations to continue into next quarter.  Without the inventory build, total sales would have been approximately $6.0 million, an increase of 15 percent versus a year ago," he said.

The Company also said it filed an updated 510(k) submission seeking market clearance from the FDA for the use of its Res-Q technology in the preparation of platelet rich plasma (PRP) from peripheral blood. In mid-October, ThermoGenesis announced a PRP cardiovascular license and distribution agreement for Res-Q with BioParadox, Inc., a newly-formed regenerative medicine company focusing on point-of-care cardiovascular therapies.

"The agreement with BioParadox places us squarely in the emerging field of PRP and is an important milestone in our initiative to create novel applications for our proprietary Res-Q technology," Engle said.

Company Awarded Federal Grant The Company also announced today that, on October 29th, it was awarded $244,000 in federal grant funding from the Department of Health and Human Service
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ThermoGenesis Corp. to Announce First Quarter Fiscal 2011 Results on November 4, 2010
2. ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement
3. ThermoGenesis Announces Fourth Quarter Revenues of $7.2 Million; Reduces Net Loss to $171,000
4. ThermoGenesis Regains Compliance With NASDAQ Listing Rules
5. ThermoGenesis Announces Reverse Stock Split Effective on NASDAQ Capital Market August 27, 2010
6. ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program
7. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
8. ThermoGenesis Announces National Institute of Health Grant
9. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
10. IRIDEX Reports Improved Third Quarter 2010 Financial Results
11. Genoptix Reports Operating Results for the Third Quarter and First Nine Months of 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  Celsion Corporation (NASDAQ: ... Company will host a conference call to discuss ... on its development programs for ThermoDox®, its proprietary ... acquired technology platforms, TheraPlas™ and TheraSilence™, in immunotherapy ... Thursday, March 12, 2015. To participate in the ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "India Pharma Outlook 2015: Accelerating ... value chain beyond Generics" report to their offering. ... from the slump in the 2013 caused by the ... 2015, growth is expected to continue to be healthy, ...
(Date:3/5/2015)... , March 5, 2015 Mallinckrodt ... global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held ... into a definitive agreement under which a subsidiary of ... Dearborn -led investor group in a transaction valued at ... closing conditions, the parties expect the transaction to be ...
Breaking Medicine Technology:Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
... Cardica, Inc. (Nasdaq: CRDC ) today announced that it will release ... Tuesday, August 17, 2010 , after the markets close. Cardica,s management will host a conference ... update on the company,s business. , , , ... , , , ...
... 4 PolyGel® is proud to announce that their ThermoActive ™ Cold & Hot ... , , ... , , ... , This is ...
Cached Medicine Technology:Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010 2PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis 2
(Date:3/5/2015)... March 05, 2015 For PASCHA Chocolate, ... most essential ingredients, the robust flavor of the cacao ... PASCHA Chocolate is free from peanuts, nuts, dairy, ... PASCHA's offering March 6th- 8th at Expo West., ... PASCHA Chocolate has broken new ground with their New ...
(Date:3/5/2015)... INTEGRATED Healthcare Strategies, a trusted compensation ... its 2015 Children’s Hospitals Executive Compensation Survey. This ... and the survey results are exclusive to participants. ... on 60 executive and director level positions, and ... subsidiary children’s hospitals. Additionally, it provided a separate ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic Nutrition ... and Arnold Fitness EXPO in Columbus, Ohio ... a display booth featuring free samples of its superior ... class-leading fat burner Synedrex. The company will also be ... its top-of-the-line supplements and miniature action figures of its ...
(Date:3/5/2015)... March 05, 2015 Nutrition Leaders, a ... is pleased to offer reformulated Millennium 500 Creatine to ... 500 is a German grade creatine supplement that has ... muscle recovery, and aid with overall strength gains in ... acts as a reserve energy source in the body ...
(Date:3/5/2015)... Utah (PRWEB) March 05, 2015 Jordan ... by LifeVest® as a treatment option for sudden cardiac ... monitors heart rhythm and can detect any life-threatening abnormalities. ... will alert the patient before delivering a treatment shock ... Dr. Adam Elhaddi of Jordan Valley Medical Center and ...
Breaking Medicine News(10 mins):Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3
... highlights need for complete, unbiased information on Medicare choices. ... ... 2008 - Medicare beneficiaries trying to sort through their healthcare ... them against overly aggressive marketing tactics by some insurance companies ...
... the resulting acne scars which last long after ... distress. Now, a new study recently published ... issue), the peer-reviewed professional journal of the American ... a novel laser device combining CO2 ablation with ...
... States to End the Tobacco Settlement Spending Spree and Direct ... WASHINGTON, Nov. 19 This Sunday, November 23, ... of the largest civil settlement in United States history. The ... 46 states and the major tobacco companies that reimbursed the ...
... Project Report Makes Recommendations for System in Critical Need of ... 17 Weaknesses in food safety policy, organization and communications ... according to a report released today by the Produce Safety ... Georgetown University . , ...
... 18 Women who undergo weight-loss surgery, known as bariatric surgery, ... lower risk for pregnancy-related diabetes and high blood pressure -- ... -- than pregnant women who are obese, according to new ... are published in the November 19 issue of JAMA. ...
... Strange Appointed to CEO position and Will Join Board, Effective ... MELVILLE, N.Y., Nov. 18 /PRNewswire-FirstCall/ -- Gentiva ... provider of comprehensive home health services, announced today that its ... Effective January 1, 2009, Tony Strange will become the Company,s ...
Cached Medicine News:Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 2Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 3Health News:New Medicare Advantage Marketing Rules Help People Make Informed Choices, Allsup Says, , 4Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 2Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 3Health News:New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring 4Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 2Health News:November 23 Marks Tenth Anniversary of the Largest Civil Settlement in U.S. History 3Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 2Health News:Salmonella Saintpaul Outbreak Exposes Food Safety Weaknesses 3Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 2Health News:Some Pregnancy-Related Complications Minimized for Women Who Have Had Weight-Loss Surgery 3Health News:Gentiva Health Services Confirms Management Succession 2Health News:Gentiva Health Services Confirms Management Succession 3Health News:Gentiva Health Services Confirms Management Succession 4
Inquire...
... DNA and RNA fragments from 100 bp ... a standard melting temperature multi-purpose agarose that ... Its high gel strength specification ensures that ... during Southern and Northern transfers. UltraPure™ ...
... Agarose with low electroendosmosis ... most DNA/RNA applications. If ... to be used as ... ligase and restriction endonucleases, ...
Excellent multi purpose agarose Nuclease-free, Gel point (1.5%): 36 1.5 C, EEO: 0.05-0.13 Gel strength (1%): > 1200 g/cm 2 ....
Medicine Products: